DJIA 17,827.75 0.00 0.00%
NASDAQ 4,787.32 0.00 0.00%
S&P 500 2,072.83 0.00 0.00%
market minute promo

38.40 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

XLRN $38.40 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $35.85
Previous Close $38.40
Daily Range $35.66 - $38.80
52-Week Range $20.88 - $57.89
Market Cap $1.2B
P/E Ratio 25.50
Dividend (Yield) $0.00 (0.0%)
Volume 200,961
Average Daily Volume 229,045
Current FY EPS -$1.25

Sector

Industry

CONTROLADORA VUELA SPON ADR REPR 10 CPOS (XLRN) Description

CONTROLADORA VUELA SPON ADR REPR 10 CPOS Website: http://www.acceleronpharma.com/

News & Commentary

A Quick Look at Celgene Corporation's Drug Development Pipeline

Celgene's drug development pipeline is currently firing on all cylinders; but can it stay that way for long? Find out as we take a closer look at the experimental drugs which matter most to Celgene.

Acceleron Pharma's (XLRN) CEO John Knopf on Q3 2014 Results - Earnings Call Transcript

Acceleron Pharma Is Due For A Market Correction And Is An Attractive Short Candidate During The Comi

Acceleron Pharma Is Due For A Market Correction And Is An Attractive Short Candidate During The Coming Months

Sector Update: Health-care Stocks Higher Pre-Bell

Sector Update: Health Care

Acceleron Initiates Phase 1 Clinical Trial With Innovative Muscle Drug ACE-083

Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline

Will Acceleron (XLRN) Continue to Surge Higher? - Tale of the Tape

Acceleron Pharma (XLRN) Jumps: Stock Rises 12.8% - Tale of the Tape

Acceleron Offers Update on Externally-Sponsored Clinical Trial of Dalantercept Monotherapy in Ovaria

Acceleron Offers Update on Externally-Sponsored Clinical Trial of Dalantercept Monotherapy in Ovarian Cancer

See More XLRN News...